XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Compensation Expense Information The following table provides information regarding our stock-based compensation:
Three Months Ended September 30, Six Months Ended September 30,
(In thousands)2022202120222021
Pre-tax share-based compensation costs charged against income$3,466 $3,219 $7,323 $5,097 
Income tax benefit recognized on compensation costs$338 $369 $875 $512 
Total fair value of options and RSUs vested during the period$64 $937 $10,289 $7,943 
Cash received from the exercise of stock options$— $503 $1,489 $2,707 
Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises$— $350 $2,895 $2,071 
Summary of Restricted Shares A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:
 
 
 
RSUs
 
Shares
(in thousands)
Weighted
Average
Grant-Date
Fair Value
Six Months Ended September 30, 2021
Unvested at March 31, 2021457.0 $33.52 
Granted170.8 45.32 
Vested (162.3)32.99 
Forfeited(24.6)30.54 
Unvested at September 30, 2021440.9 38.45 
Vested at September 30, 2021152.3 33.92 
   
Six Months Ended September 30, 2022
Unvested at March 31, 2022440.9 $38.45 
Granted148.9 55.04 
Incremental performance shares42.4 — 
Vested (222.4)32.05 
Unvested at September 30, 2022409.8 47.14 
Vested at September 30, 2022108.5 36.54 
Fair Value of Options Granted
The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:
 Six Months Ended September 30,
 2022 2021
Expected volatility
30.8% - 30.9%
 
31.1% - 31.9%
Expected dividends$—  $— 
Expected term in years
6.0 to 7.0
 
6.0 to 7.0
Risk-free rate
2.8% to 2.9%
 
1.0% to 1.3%
Weighted average grant date fair value of options granted$20.10 $14.87 
Stock Option Activity A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:
 
 
 
 
Options
 
 
Shares
(in thousands)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Six Months Ended September 30, 2021
Outstanding at March 31, 20211,114.9 $37.92 
Granted234.2 44.74 
Exercised(87.6)30.91 
Forfeited(13.7)37.83 
Expired(8.5)56.63 
Outstanding at September 30, 20211,239.3 39.58 6.7$20,593 
Vested at September 30, 2021759.7 39.06 5.3$13,060 
Six Months Ended September 30, 2022    
Outstanding at March 31, 20221,100.9 $40.62 
Granted197.6 54.48 
Exercised(39.1)38.04 
Outstanding at September 30, 20221,259.4 42.88 6.6$10,963 
Vested at September 30, 2022830.8 40.04 5.4$9,403